Nedderman Wade, Bendel Emily, Anderson Jason, Reisenauer Chris, Takahashi Edwin, Knavel Koepsel Erica, Polites Stephanie, Thompson Scott
Department of Radiology, Mayo Clinic, Rochester, MN.
Department of Pediatrics, Division of Pediatric Cardiology, Mayo Clinic, Rochester, MN.
Mayo Clin Proc Innov Qual Outcomes. 2024 Oct 8;8(6):494-501. doi: 10.1016/j.mayocpiqo.2024.08.003. eCollection 2024 Dec.
To determine the prevalence of systemic embolic complications after oil-based contrast lymphangiography.
A retrospective medical record review of all patients undergoing oil-based lymphangiographic procedures from January 1, 2000, to December 31, 2021 was performed to identify the following: (a) the rate of systemic embolic complications after the procedure; (b) the presence of preprocedure echocardiographic assessment for right-to-left shunting; and (c) the presence of right-to-left shunting after a systemic embolic complication.
A total of 350 patients (200 male, 57%) underwent 400 oil-based lymphangiographic procedures. A total of 2 systemic embolic complications occurred for a prevalence of 0.5% (2/400). Preprocedure echocardiography was performed in 226 patients (226/350, 65%). Identification of a right-to-left shunt was made in 25 patients (25/226, 11%, with the majority reporting shunting at rest (23/25, 92%). Of the patients with systemic embolic complications, one had multifocal systemic oil contrast emboli, and one had a large territorial cerebrovascular infarct without the presence of oil-based contrast noted. Both cases underwent preprocedure echocardiography reporting a structurally normal heart with no evidence of a shunt through color flow Doppler evaluation, but neither case had undergone a true shunt study. Both patients were identified to have a right-to-left shunt during the dedicated echocardiographic shunt study postprocedure.
Risk of a systemic embolic complication after oil-based contrast lymphangiography is rare but can be catastrophic. A standardized assessment for patients undergoing the procedure may be necessary to identify those at risk and to allow for appropriate preventive strategies to be employed.
确定油基造影剂淋巴管造影术后全身性栓塞并发症的发生率。
对2000年1月1日至2021年12月31日期间接受油基淋巴管造影检查的所有患者进行回顾性病历审查,以确定以下内容:(a) 术后全身性栓塞并发症的发生率;(b) 术前超声心动图评估是否存在右向左分流;(c) 全身性栓塞并发症发生后是否存在右向左分流。
共有350例患者(200例男性,占57%)接受了400次油基淋巴管造影检查。共发生2例全身性栓塞并发症,发生率为0.5%(2/400)。226例患者(226/350,占65%)进行了术前超声心动图检查。25例患者(25/226,占11%)发现存在右向左分流,其中大多数患者(23/25,占92%)静息时存在分流。在发生全身性栓塞并发症的患者中,1例有多灶性全身性油造影剂栓塞,1例有大面积脑梗死区域,未发现油基造影剂。两例患者术前均进行了超声心动图检查,报告心脏结构正常,彩色多普勒血流评估未发现分流证据,但两例患者均未进行真正的分流检查。术后专门的超声心动图分流检查发现,这两名患者均存在右向左分流。
油基造影剂淋巴管造影术后发生全身性栓塞并发症的风险虽罕见,但可能是灾难性的。对接受该检查的患者进行标准化评估可能有必要,以识别有风险的患者,并采取适当的预防策略。